Therefore, it is now possible to test this hypothesis, for example, in a sufficiently large sample size to determine if ABCB8 is overexpressed in human doxorubicin‐resistant tumor samples versus treatment‐naïve tumor samples. This evidence concerns the gene ABCB8 and neoplasm.